Tags

antibody candidate Phase 3

Harbour BioMed advances long-acting antibody candidate to Phase 3 trial

Harbour BioMed advances long-acting antibody candidate to Phase 3 trial

September 10, 2026 | 10:42
Harbour BioMed announced positive Phase 2 clinical results for TSLP-targeting antibody HBM9378 in asthma patients, prompting partner Windward Bio to launch a Phase 3 study.

Latest News

Vietnam tops ASEAN as most attractive to European businesses

Vietnam tops ASEAN as most attractive to European businesses

Vietnam's life insurance sector eyes growth amid widening protection gap

Vietnam's life insurance sector eyes growth amid widening protection gap

BIG Investment founder transfers 1.3 million shares to Brookland Group

BIG Investment founder transfers 1.3 million shares to Brookland Group

Long Thanh Airport passenger fees under review ahead of launch

Long Thanh Airport passenger fees under review ahead of launch

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020